Cargando…

Autoantibodies in very early rheumatoid arthritis: diagnostic tools or pathogenic players?

Detalles Bibliográficos
Autores principales:	Steiner, G, Nell, V, Eberl, G, Hayer, S, Machold, K, Hoefler, E, Smolen, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833909/ http://dx.doi.org/10.1186/ar919

Ejemplares similares

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
por: Nell, V, et al.
Publicado: (2003)

Autoantibodies in rheumatoid arthritis and their clinical significance
por: Steiner, Günter, et al.
Publicado: (2002)

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
por: Aletaha, Daniel, et al.
Publicado: (2005)

Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis
por: Sieghart, Daniela, et al.
Publicado: (2018)

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
por: Machold, Klaus P, et al.
Publicado: (2006)

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2000)

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
por: Kapral, Theresa, et al.
Publicado: (2007)

Functional Analysis of Autoantibody Signatures in Rheumatoid Arthritis
por: Milchram, Lisa, et al.
Publicado: (2022)

Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis
por: Gärtner, M, et al.
Publicado: (2016)

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
por: van Boekel, Martinus AM, et al.
Publicado: (2002)

Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure
por: Kapral, Theresa, et al.
Publicado: (2006)

Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?
por: Hayer, S, et al.
Publicado: (2001)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Schett, G, et al.
Publicado: (2003)

Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus
por: Robinson, W, et al.
Publicado: (2002)

New autoantibodies in early rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2013)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

The role of autoantibodies in the pathophysiology of rheumatoid arthritis
por: Derksen, V. F. A. M., et al.
Publicado: (2017)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort
por: Biliavska, Iuliia, et al.
Publicado: (2013)

B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
por: Bugatti, Serena, et al.
Publicado: (2014)

Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2010)

Novel multiplex technology for diagnostic characterization of rheumatoid arthritis
por: Chandra, Piyanka E, et al.
Publicado: (2011)

Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
por: Song, Y.W., et al.
Publicado: (2010)

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis
por: György, Bence, et al.
Publicado: (2008)

Autoantibodies in normals – the value of predicting rheumatoid arthritis
por: Dörner, Thomas, et al.
Publicado: (2004)

The Spectrum and Clinical Significance of Autoantibodies in Rheumatoid Arthritis
por: Castelar-Pinheiro, Geraldo da Rocha, et al.
Publicado: (2015)

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
por: Rönnelid, Johan, et al.
Publicado: (2021)

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation
por: Görtz, B, et al.
Publicado: (2004)

Autoantibodies in psoriatic arthritis: are they of pathogenic relevance?
por: Zhu, Jing, et al.
Publicado: (2020)

The science of rheumatoid arthritis: a prelude
por: Smolen, Josef S
Publicado: (2005)

Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology
por: Volkov, Mikhail, et al.
Publicado: (2019)

Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
por: Sokolova, Maria V., et al.
Publicado: (2021)

Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)

Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
por: Paroli, Marino, et al.
Publicado: (2023)

Subclass distribution of IgG autoantibodies to deiminated fibrinogen in rheumatoid arthritis
por: Chapuy-Regaud, S, et al.
Publicado: (2003)

From perinuclear factor to citrulline, a target structure for autoantibodies in rheumatoid arthritis
por: Serre, G
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_jk898erpahur3jnhstb54dknpm